Notice2024-17576

Alliance for Innovation on Maternal Health-Community Care Initiative (AIM CCI)/Non-Competitive Supplement

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
August 8, 2024

Issuing agencies

Health and Human Services DepartmentHealth Resources and Services Administration

Abstract

HRSA is providing non-competitive supplemental funds in fiscal year (FY) 2024 to pilot test community-based methods and/or maternal safety bundles to address hypertension during pregnancy and the postpartum period to improve maternal health.

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 153 (Thursday, August 8, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 153 (Thursday, August 8, 2024)]
[Notices]
[Pages 64940-64941]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-17576]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Alliance for Innovation on Maternal Health--Community Care 
Initiative (AIM CCI)/Non-Competitive Supplement

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice of non-competitive supplemental funding.

-----------------------------------------------------------------------

SUMMARY: HRSA is providing non-competitive supplemental funds in

[[Page 64941]]

fiscal year (FY) 2024 to pilot test community-based methods and/or 
maternal safety bundles to address hypertension during pregnancy and 
the postpartum period to improve maternal health.

FOR FURTHER INFORMATION CONTACT: India Hinton, Public Health Analyst, 
Division of Healthy Start and Perinatal Services, Maternal and Child 
Health Bureau, HRSA, at <a href="/cdn-cgi/l/email-protection#59101130372d363719312b2a38773e362f"><span class="__cf_email__" data-cfemail="0b424362657f64654b6379786a256c647d">[email&#160;protected]</span></a> and via phone at (301) 945-
5235.

SUPPLEMENTARY INFORMATION: Intended Recipient(s) of the Award: Funding 
for the AIM CCI program recipient through a Non-Competitive Supplement 
to extend the project period by 12 months to pilot test community-based 
methods and/or maternal safety bundles targeting hypertension during 
pregnancy and the postpartum period to improve maternal health.
    Amount of Competitive or Non-Competitive Award(s): One award up to 
$1,800,000.
    Project Period: September 30, 2019-September 29, 2025.
    Assistance Listing (CFDA) Number: 93.100.
    Award Instrument: Non-competitive supplement to a cooperative 
agreement.
    Authority: 42 U.S.C. 701(a)(2) (Social Security Act, title V, sec. 
501(a)(2)).

                                      Table 1--Recipients and Award Amounts
----------------------------------------------------------------------------------------------------------------
              Grant No.                  Award recipient name         City, State              Award amount
----------------------------------------------------------------------------------------------------------------
U7BMC33635...........................  National Healthy Start   Washington, DC.........  Up to $1,800,000.
                                        Association.
----------------------------------------------------------------------------------------------------------------

    Justification: The majority of pregnancy-related deaths occur 
following delivery. Improving health care outside of the labor and 
delivery setting is an important strategy for reducing pregnancy-
related deaths. The planned supplemental award is within the scope of 
the most recent funding opportunity (HRSA-19-109) program purpose, 
which aims to: (1) support the development and implementation of non-
hospital focused maternal safety bundles within community-based 
organizations and outpatient clinical settings across the United States 
and (2) build upon the foundational work of AIM by addressing 
preventable maternal mortality and severe maternal morbidity among 
pregnant and postpartum women outside of hospital and birthing facility 
settings.
    HRSA will award a non-competitive supplement not to exceed $1.8 
million to support the implementation of community-based activities, to 
include maternal safety bundles and supporting resources, with a focus 
on hypertension during pregnancy and the postpartum period. Lessons 
learned from the pilot will be used to strengthen and inform community-
based approaches targeting hypertension in pregnant and postpartum 
people.

Carole Johnson,
Administrator.
[FR Doc. 2024-17576 Filed 8-7-24; 8:45 am]
BILLING CODE 4165-15-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on August 8, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.